Meiji Holdings Co.,Ltd.
Notice Concerning Transfer of Shares of a Consolidated Subsidiary
Earlier from Meiji
- Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical’s Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ
- Notice concerning Completion of Payment in Full and Partial Forfeiture of Rights for Disposal of Treasury Stock under Restricted Stock Incentive Plan
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 [Based on Japanese GAAP]
- Notice concerning Completion of Payment in Full for Disposal of Treasury Stock for Restricted Stock Compensation for Directors